Page 1,525«..1020..1,5241,5251,5261,527..1,5301,540..»

Clinical Cardiology Made Ridiculously Simple: Michael A …

Posted: Published on August 22nd, 2018

Michael A. Chizner, M.D., renowned cardiologist, Founder and former Chief Medical Director of The Heart Center of Excellence of Broward Health, was recently named in the Top 1% in the Nation in the first Top Doctors List compiled by U.S. News & World Report. Dr. Chizner graduated with highest honors from Cornell University Medical College. He received his medical residency training at the New York Hospital-Cornell Medical Center, and his cardiology training at Georgetown University, where he received the Distinguished Alumnus Award. He is Board Certified in Internal Medicine and Cardiology, and is a Fellow of the American College of Physicians, American College of Cardiology, and American Heart Association. He is a Clinical Professor of Medicine at the University of Florida College of Medicine, the University of Miami Miller School of Medicine, Nova Southeastern University College of Osteopathic Medicine, the Charles E. Schmidt College of Medicine at Florida Atlantic University, and Barry University. Dr. Chizner has served as Chairman and Vice Chairman of the Florida Board of Medicine. He has also served on the Editorial Advisory Boards of national cardiology journals, and has been Director and Keynote Speaker at national and regional medical education conferences. He has written and edited … Continue reading →

Posted in Clinical Cardiology | Comments Off on Clinical Cardiology Made Ridiculously Simple: Michael A …

Stem Cell Treatment for Cerebral Palsy – Beike Biotechnology

Posted: Published on August 21st, 2018

Nerve Growth Factor (NGF) Nerve growth factor (NGF) is a member of the neurotrophic factor (neurotrophin, NTFS) family, which can prevent the death of nerve cells and has many features of typical neurotransmitter molecules. NGF plays an important role in the development and growth of nerve cells. NGF is synthesized and secreted by tissues (corneal epithelial, endothelial, and corneal stromal cells), and it can be up-taken by sympathetic or sensory nerve endings and then transported to be stored in neuronal cell bodies where it can promote the growth and differentiation of nerve cells. NGF can exert neurotrophic effects on injured nerves and promote neurogenesis (the process of generating neurons from stem cells) that is closely related to the development and functional maintenance and repair of the central nervous system. It is also capable of promoting the regeneration of injured neurons in the peripheral nervous system, improving the pathology of neurons and protecting the nerves against hypoxia (lack of oxygen)/ischemia (lack of blood supply). Here is the original post: Stem Cell Treatment for Cerebral Palsy - Beike Biotechnology … Continue reading →

Posted in Cerebral Palsy Treatment | Comments Off on Stem Cell Treatment for Cerebral Palsy – Beike Biotechnology

Stem Cell Treatment for Spinal Cord Injury …

Posted: Published on August 21st, 2018

Nerve Growth Factor (NGF) Nerve growth factor (NGF) is a member of the neurotrophic factor (neurotrophin, NTFS) family, which can prevent the death of nerve cells and has many features of typical neurotransmitter molecules. NGF plays an important role in the development and growth of nerve cells. NGF is synthesized and secreted by tissues (corneal epithelial, endothelial, and corneal stromal cells), and it can be up-taken by sympathetic or sensory nerve endings and then transported to be stored in neuronal cell bodies where it can promote the growth and differentiation of nerve cells. NGF can exert neurotrophic effects on injured nerves and promote neurogenesis (the process of generating neurons from stem cells) that is closely related to the development and functional maintenance and repair of the central nervous system. It is also capable of promoting the regeneration of injured neurons in the peripheral nervous system, improving the pathology of neurons and protecting the nerves against hypoxia (lack of oxygen)/ischemia (lack of blood supply). The rest is here: Stem Cell Treatment for Spinal Cord Injury ... … Continue reading →

Posted in Spinal Cord Injury Treatment | Comments Off on Stem Cell Treatment for Spinal Cord Injury …

Coronary Heart Disease – Ischaemic heart disease – British …

Posted: Published on August 21st, 2018

Over time, fatty material called atheroma can build up inside the walls of your arteries. This is known as atherosclerosis.If this build up happens in the arteries that supply your heart with blood, it is called coronary heart disease. Eventually, your arteries may become so narrow because of this build up that they cannot deliver enough oxygen-rich blood to your heart. The pain and discomfort you may feel as a result of this is called angina. If a piece of atheroma breaks off it may cause a blood clot (blockage) to form. If it blocks your coronary artery and cuts off the supply of oxygen-rich blood to your heart muscle, your heart may become permanently damaged. This is known as a heart attack. A risk factor is something that increases your likelihood of getting a disease. There are several factors that can increase the risk of developing CHD. The main ones are: The more risk factors you have, the more likely you are to develop CHD. Even though you cant change all your risk factors, there is plenty you can do to reduce your risk and help to protect your heart. You can have a freeNHS health check to assess … Continue reading →

Posted in ALS Treatment | Comments Off on Coronary Heart Disease – Ischaemic heart disease – British …

Regeneration (biology) – Wikipedia

Posted: Published on August 21st, 2018

In biology, regeneration is the process of renewal, restoration, and growth that makes genomes, cells, organisms, and ecosystems resilient to natural fluctuations or events that cause disturbance or damage.[1] Every species is capable of regeneration, from bacteria to humans.[2][3] Regeneration can either be complete[4] where the new tissue is the same as the lost tissue,[4] or incomplete[5] where after the necrotic tissue comes fibrosis.[5] At its most elementary level, regeneration is mediated by the molecular processes of gene regulation.[6][7] Regeneration in biology, however, mainly refers to the morphogenic processes that characterize the phenotypic plasticity of traits allowing multi-cellular organisms to repair and maintain the integrity of their physiological and morphological states. Above the genetic level, regeneration is fundamentally regulated by asexual cellular processes.[8] Regeneration is different from reproduction. For example, hydra perform regeneration but reproduce by the method of budding. The hydra and the planarian flatworm have long served as model organisms for their highly adaptive regenerative capabilities.[9] Once wounded, their cells become activated and start to remodel tissues and organs back to the pre-existing state.[10] The Caudata ("urodeles"; salamanders and newts), an order of tailed amphibians, is possibly the most adept vertebrate group at regeneration, given their capability of … Continue reading →

Posted in Cardiac Regeneration | Comments Off on Regeneration (biology) – Wikipedia

World Cardiology and Cardiologist Meeting

Posted: Published on August 21st, 2018

Sessions/Tracks Track 1 : Heart Diseases and Failure Heart diseasesare the disorders that affect the heart.Diseasesunder theheart diseasesumbrella includeblood vessel diseases, such ascoronary arterydisease,heart rhythmproblems(arrhythmias), and heart defects i.e. congenital heart defects,Rheumatic heart disease, Hypertensive heart disease,Ischemic heart disease, Hypertension etc. Heart failureis a condition in which the heart can't pump enough blood to meet the body's needs. The term Heart failure doesnt mean that the heart has stopped its functions. CHD can lead to heart failure by weakening theheart muscleover time. However,heart failureis a serious condition that requires medical care. Related Conferences: 29th World Cardiology Conference November 19-20, 2018 Edinburgh, Scotland; Clinical Cardiology and Cardiovascular Disease May 24-25, 2018 London, UK; 24th World Cardiology Conference 17-18 September,2018 Hong Kong; 27th European Cardiology Conference October 22-24, 2018 Rome, Italy; Global Cardiology Summit October 22-23, 2018 Osaka, Japan; International Heart Conference Singapore City, Singapore August 13-15, 2018; Pediatric Heart Diseases and Pediatric Health October 08-09, 2018 Related Societies: Cardiology Conferences 2018,Cardiology Congress 2018,Upcoming Cardiology Conferences 2018,World Cardiology Conferences2018,Cardiology Conferences USA,Cardiology Conferences Europe, Cardiology Conferences Asia Pacific,Cardiology Conferences Middle East,Heart Congress 2018,Heart Conferences 2018,Cardiologist Meet 2018,Heart Diseases Conferences 2018,Women Cardiology Conferences 2018,Cardiology Nursing Conferences 2018,Sweden Conferences 2018,Hypertension Conferences 2018 America: American Society … Continue reading →

Posted in Cardiac Regeneration | Comments Off on World Cardiology and Cardiologist Meeting

Left ventricular hypertrophy – Wikipedia

Posted: Published on August 20th, 2018

Left ventricular hypertrophy (LVH) is thickening of the heart muscle of the left ventricle of the heart, that is, left-sided ventricular hypertrophy. While ventricular hypertrophy occurs naturally as a reaction to aerobic exercise and strength training, it is most frequently referred to as a pathological reaction to cardiovascular disease, or high blood pressure.[1] It is one aspect of ventricular remodeling. While LVH itself is not a disease, it is usually a marker for disease involving the heart.[2] Disease processes that can cause LVH include any disease that increases the afterload that the heart has to contract against, and some primary diseases of the muscle of the heart. Causes of increased afterload that can cause LVH include aortic stenosis, aortic insufficiency and hypertension. Primary disease of the muscle of the heart that cause LVH are known as hypertrophic cardiomyopathies, which can lead into heart failure. Long-standing mitral insufficiency also leads to LVH as a compensatory mechanism. Associated genes include OGN, osteoglycin.[3] The principal method to diagnose LVH is echocardiography, with which the thickness of the muscle of the heart can be measured. The electrocardiogram (ECG) often shows signs of increased voltage from the heart in individuals with LVH, so this is … Continue reading →

Posted in Ventricular Remodeling | Comments Off on Left ventricular hypertrophy – Wikipedia

Eczema Treatments for Kids – verywellhealth.com

Posted: Published on August 19th, 2018

Eczema, also known as atopic dermatitis, is a good example of a common and exasperating condition of childhoodcommon because around 10 percent of kids in the U.S. have this skin disease, according to the National Institutes of Health. And exasperating because there's no cureand it can be tricky to treat. It's a little like a boomerang: Although it's possible to get the rash under control, it's likely to come back periodically in what is called an eczema flare. The telltale symptom of eczema is anitchy rashthat typically makes a debut in early infancy but can first show up as kids as old as 5. It's sometimes mistaken for other rashes, such ascontact dermatitis,heat rash,seborrheic dermatitis, and psoriasis, but it does have unique characteristics. A rash caused by eczemausually looks like patches of rough, red, itchy skin on the forehead, cheeks, arms and legs of infants, and in the creases or insides of the elbows, knees, and ankles of older kids. On the bright side, if your child has eczema now in all likelihood he won't have to deal with it forever. For most kids, it eases up or even disappears entirely as they get older. In the meantime, there are … Continue reading →

Posted in Eczema | Comments Off on Eczema Treatments for Kids – verywellhealth.com

Board of Directors Summary – Victor Chang Cardiac Research …

Posted: Published on August 18th, 2018

Executive DirectorAO, FAA, MBBS(HONS), MD, FRACP, FACP, FAHA, FAHMS, GAICD Professor Graham is the inaugural Executive Director of the Victor Chang Cardiac Research Institute, and a member of its Finance & Risk, Appeals, and Media and Communications Committees. He is the Des Renford Professor of Medicine, and Professor of Biotechnology and Biomolecular Science, University of New South Wales, and Professor (adjunct) of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio. Prof Graham is a Fellow of the Australian Academy of Science and the Australian Academy of Health & Medical Sciences, and foreign member, Royal Danish Academy of Sciences and Letters. He is a member of the American Association for Clinical Research, the American Society of Clinical Investigation and the American Heart Association, and a Life Member, Heart Foundation of Australia. Professor Graham is head of the Cardiac Receptor Biology Laboratory at the Victor Chang Cardiac Research Institute Originally posted here: Board of Directors Summary - Victor Chang Cardiac Research ... … Continue reading →

Posted in Batten Disease Treatment | Comments Off on Board of Directors Summary – Victor Chang Cardiac Research …

TARA / Innovating predictive cardiac physiology

Posted: Published on August 18th, 2018

Director John Baldoni is Senior Vice President,In silicoDrug Discovery, in GSK Pharma R&D. This department will usein silicomethods to identify patient needs, explore molecular interventions to address those needs and design and conduct clinical trials to test the medical hypothesis. Using these methodologies, the conventional empirical design make test cycle will be dramatically reduced. The intent is to discover medicines at higher velocity, with greater precision and at dramatically lower cost compared to current approaches. Prior to this, John was Senior Vice President, Platform Technology and Science (PTS), in GSK. The work of PTS span the entire drug discovery and development process, from preclinical activities leading to clinical candidate selection through commercial launch. This accountability covered the discovery and manufacture of small molecules, biopharmaceuticals, and cell and gene therapies. John joined GSK in 1989 and has worked in the pharmaceutical industry for 37 years. His experience spans new chemical entity design, development and commercialization, and biopharmaceutical development. In progressing to his current role, John has held various positions at GSK including Senior Vice President, Preclinical Development; Vice President, Product Development; Director, Product Development; and Assistant Director, Biopharmaceutical Formulation Development, among others. He has led several key cross-functional strategic initiatives, such … Continue reading →

Posted in Batten Disease Treatment | Comments Off on TARA / Innovating predictive cardiac physiology

Page 1,525«..1020..1,5241,5251,5261,527..1,5301,540..»